Please login to the form below
MiroBio
This page shows the latest MiroBio news and features for those working in and with pharma, biotech and healthcare.
Gilead completes acquisition of MiroBio in $405m cash deal
The deal includes MiroBio’s proprietary discovery platform and its entire portfolio of immune inhibitory receptor agonists. ... MiroBio has a deep understanding of checkpoint receptor signalling and a proprietary approach to select and generate
Latest news
-
Gilead Sciences set to acquire MiroBio in deal worth over $400m
Gilead Sciences has announced its plans to acquire UK-based biotechnology company MiroBio. ... The acquisition will allow Gilead to utilise MiroBio’s proprietary discovery platform and entire portfolio of immune inhibitory receptor agonists.
-
UK immunology biotech MiroBio launches with $34m fundraising
MiroBio’s Series A financing was co-led by Oxford Sciences Innovation and Samsara Biocapital, with Advent Life Sciences and SR One also joining the round. ... MiroBio has a robust technology and the ambition to bring new medicines to patients in need
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Bristol Myers Squibb presents positive results for idiopathic pulmonary fibrosis drug
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
